What You Should Know About Prostate Cancer

According to the American Cancer Society, more than two million men in the US are prostate cancer survivors. Last year an estimated 23,000 of men in Oklahoma were diagnosed with the disease. Let’s discuss some myths associated with prostate cancer.


Myth 1: Only men 70-years-ols and above get prostate cancer

A lot of people think it is older men, much older, seventy years or older. That is not true because actually you will see that there are men who develop prostate cancer in their forties and fifties. So it makes it very important that you should be screened and make sure you have physical exams. Because those who found with prostate cancer earlier can be much more aggressive than those found with it later.

Myth 2: Changes in urinary function are the primary symptoms of prostate cancer


Honestly, I think I would be hard-pressed to find a lot of people on the street that could identify the primary symptoms of prostate cancer. So if you are middle-aged male, you should know the symptoms in order to be aware what to do. The symptoms can be quite varied. So anything from erectile dysfunction, blood in the urine, blood in the sperm, those things can be a very dangerous sign of prostate cancer.

Scheduling a prostate exam not exactly a date on the calendar you probably circle look forward to but we talk about the symptoms, and now we will talk about the treatments for prostate cancer.

Myth 3: Surgery and radiation are the only treatment options for advanced prostate cancer


Some people think that only surgery and radiation are the common treatments available. The FDA recently released two medications or two therapies that are available for those with advanced prostate cancer. The first one is called Provenge.

They extract white blood cells from your bloodstream. What they do is train these cells, program them to destroy prostate cancer. So after they have been programmed, these cells injected back into your system, and they go directly to where the prostate cancer is located. The survival is improved with this therapy. It is a vaccine almost against prostate cancer.